InflaRx NV (IFRX) Receives European Approval to Initiate Phase II Clinical Trial with IFX-1 in ANCA-Associated Vasculitis – StreetInsider.com

InflaRx NV (IFRX) Receives European Approval to Initiate Phase II Clinical Trial with IFX-1 in ANCA-Associated Vasculitis – StreetInsider.com

InflaRx NV (IFRX) Receives European Approval to Initiate Phase II Clinical Trial with IFX-1 in ANCA-Associated Vasculitis – StreetInsider.com
Published on 2018-12-19